ASCO: Genentech touts bispecific data for DLBCL calling it ‘groundbreaking’ for heavily pretreated patients

May 27, 2022 San Francisco Biotechnology Network News News Comments Off on ASCO: Genentech touts bispecific data for DLBCL calling it ‘groundbreaking’ for heavily pretreated patients
ASCO: Genentech touts bispecific data for DLBCL calling it 'groundbreaking' for heavily pretreated patients aarmstrong Thu, 05/26/2022 - 20:20

Click to view original post